STAT3 and cholangiocarcinoma: reported that CXCL6 overexpression in HCC cells activates the JAK‐STAT3 pathway in hepatocytes through paracrine signaling.[72] Among liver cancers, the incidence of CCA is second only to HCC, yet the molecular mechanisms of CXCLs in CCA have barely been explored.